{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:26:39Z","timestamp":1786119999951,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/ftd.0b013e3182263981","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T13:02:04Z","timestamp":1310130124000},"page":"453-459","source":"Crossref","is-referenced-by-count":23,"title":["Evaluation of the Abbott ARCHITECT i2000 Sirolimus Assay and Comparison With the Abbott IMx Sirolimus Assay and an Established Liquid Chromatography\u2013Tandem Mass Spectrometry Method"],"prefix":"10.1097","volume":"33","author":[{"given":"Kamisha L","family":"Johnson-Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumo","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendolyn A","family":"McMillin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barun K","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210129","first-page":"SS42","article-title":"Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity.","volume":"71","author":"Campistol","year":"2001","journal-title":"Transplant"},{"key":"R2-13-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1034\/j.1399-0012.2002.01119.x","article-title":"Calcineurin inhibitor nephrotoxicity: reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy.","volume":"16","author":"Pilmore","year":"2002","journal-title":"Clin Transplant"},{"key":"R3-13-20210129","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation.","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"R4-13-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.trim.2008.08.011","article-title":"Sirolimus-based, calcineurin-inhibitor sparing immunotherapy, long-term (6-year) results.","volume":"20","author":"Conti","year":"2008","journal-title":"Transplant Immunol"},{"key":"R5-13-20210129","doi-asserted-by":"crossref","first-page":"125S","DOI":"10.1016\/S0041-1345(03)00226-4","article-title":"Kidney transplantation without calcineurin inhibitors using sirolimus.","volume":"35","author":"Stegall","year":"2003","journal-title":"Transplant Proc"},{"key":"R6-13-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2009.09.009","article-title":"Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS\/MS) and Abbott IMx methods.","volume":"410","author":"De","year":"2009","journal-title":"Clin Chim Acta"},{"key":"R7-13-20210129","doi-asserted-by":"crossref","first-page":"B14","DOI":"10.1016\/S0149-2918(00)89019-0","article-title":"A practical guide to the analysis of sirolimus using high performance liquid chromatography with ultraviolet detection.","volume":"22","author":"Napoli","year":"2000","journal-title":"Clin Ther"},{"key":"R8-13-20210129","doi-asserted-by":"crossref","first-page":"B25","DOI":"10.1016\/S0149-2918(00)89020-7","article-title":"Therapeutic monitoring of sirolimus in human whole-blood samples by high-performance liquid chromatography.","volume":"22","author":"Maleki","year":"2000","journal-title":"Clin Ther"},{"key":"R9-13-20210129","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/clinchem\/46.8.1179","article-title":"Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection.","volume":"46","author":"Holt","year":"2000","journal-title":"Clin Chem"},{"key":"R10-13-20210129","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00007691-200010000-00017","article-title":"Simultaneous quantification of tacrolimus and sirolimus, in human blood, by high performance liquid chromatography-tandem mass spectrometry.","volume":"22","author":"Taylor","year":"2000","journal-title":"Ther Drug Monit"},{"key":"R11-13-20210129","doi-asserted-by":"crossref","first-page":"B49","DOI":"10.1016\/S0149-2918(00)89022-0","article-title":"An immunoassay for the measurement of sirolimus.","volume":"22","author":"Jones","year":"2000","journal-title":"Clin Ther"},{"key":"R12-13-20210129","doi-asserted-by":"crossref","first-page":"B71","DOI":"10.1016\/S0149-2918(00)89024-4","article-title":"The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients.","volume":"22","author":"Salm","year":"2000","journal-title":"Clin Ther"},{"key":"R13-13-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/03009730802608254","article-title":"Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method.","volume":"114","author":"Bouzas","year":"2009","journal-title":"Ups J Med Sci"},{"key":"R14-13-20210129","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.clinbiochem.2009.06.018","article-title":"Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer.","volume":"42","author":"Schmid","year":"2009","journal-title":"Clin Biochem"},{"key":"R15-13-20210129","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1373\/clinchem.2004.037416","article-title":"Simple extraction protocol for analysis of immunosuppressant drugs in whole blood.","volume":"50","author":"Annesley","year":"2004","journal-title":"Clin Chem"},{"key":"R17-13-20210129","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clinbiochem.2006.01.017","article-title":"Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus.","volume":"39","author":"Wilson","year":"2006","journal-title":"Clin Biochem"},{"key":"R18-13-20210129","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clinbiochem.2006.08.005","article-title":"Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay.","volume":"40","author":"Bouzas","year":"2007","journal-title":"Clin Biochem"},{"key":"R19-13-20210129","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.transproceed.2010.01.059","article-title":"Relationship between everolimus blood concentration assessed using the Innofluor Certican fluorescence polarization immunoassay and the Architect i2000 System sirolimus chemiluminescent microparticle immunoassay.","volume":"42","author":"Coentrao","year":"2010","journal-title":"Transplant Proc"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e3182263981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:35:33Z","timestamp":1786044933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-201108000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3182263981","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}